Literature DB >> 31395490

Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis.

Cynthia Z Burton1, Ivy F Tso2, Ricardo E Carrión3, Tara Niendam4, Steven Adelsheim5, Andrea M Auther3, Barbara A Cornblatt3, Cameron S Carter4, Ryan Melton6, Tamara G Sale6, Stephan F Taylor2, William R McFarlane7.   

Abstract

BACKGROUND: As efforts intensify to intervene early among those at risk for psychosis, examination of the relationship between presenting psychopathology and long-term functional outcome may guide treatment decision-making and offer a means to prevent or reduce chronic disability.
METHODS: Data were collected through the Early Detection and Intervention for the Prevention of Psychosis Program (EDIPPP), a multisite national trial testing the efficacy of an early intervention for youth at risk of developing psychosis. Participants were followed prospectively and completed comprehensive evaluations at 6, 12, and 24 months, including the Structured Interview for Prodromal Syndromes (SIPS) and the Global Social and Role Functioning Scales. The present analyses included 327 participants and examined the relationships between baseline symptoms and longitudinal global social and role functioning using a linear mixed modeling approach.
RESULTS: Higher baseline negative symptoms and deteriorated thought process predicted worse social and role functioning in the follow-up period. The effect of negative symptoms on social functioning, however, was moderated by positive symptoms, and the relationship between positive symptoms and social functioning changed over time. Baseline positive symptoms, distress, and level of symptom severity were not predictors of either social or role functioning.
CONCLUSIONS: Baseline negative symptoms and thought disorder appear to predict functional outcome for up to two years among adolescents and young adults at risk for psychosis. Developing effective interventions to target these symptoms may be critical to promote functional recovery among those experiencing attenuated symptoms or a first episode of psychosis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Attenuated psychosis; Clinical high risk; Functioning; Negative symptoms; Positive symptoms

Mesh:

Year:  2019        PMID: 31395490      PMCID: PMC6791749          DOI: 10.1016/j.schres.2019.07.048

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  25 in total

1.  Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.

Authors:  Anthony O Ahmed; Gregory P Strauss; Robert W Buchanan; Brian Kirkpatrick; William T Carpenter
Journal:  Schizophr Bull       Date:  2014-11-14       Impact factor: 9.306

2.  The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.

Authors:  Eric C Meyer; Ricardo E Carrión; Barbara A Cornblatt; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen; Larry J Seidman
Journal:  Schizophr Bull       Date:  2014-02-18       Impact factor: 9.306

3.  Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.

Authors:  Tae Young Lee; Sung Nyun Kim; Christoph U Correll; Min Soo Byun; Euitae Kim; Joon Hwan Jang; Do-Hyung Kang; Je-Yeon Yun; Jun Soo Kwon
Journal:  Schizophr Res       Date:  2014-05-09       Impact factor: 4.939

Review 4.  Negative symptoms of schizophrenia: new developments and unanswered research questions.

Authors:  Silvana Galderisi; Armida Mucci; Robert W Buchanan; Celso Arango
Journal:  Lancet Psychiatry       Date:  2018-03-27       Impact factor: 27.083

5.  Prediction of functional outcome in individuals at clinical high risk for psychosis.

Authors:  Ricardo E Carrión; Danielle McLaughlin; Terry E Goldberg; Andrea M Auther; Ruth H Olsen; Doreen M Olvet; Christoph U Correll; Barbara A Cornblatt
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

6.  Schizophrenia heterogeneity revisited: Clinical, cognitive, and psychosocial correlates of statistically-derived negative symptoms subgroups.

Authors:  Anthony O Ahmed; Gregory P Strauss; Robert W Buchanan; Brian Kirkpatrick; William T Carpenter
Journal:  J Psychiatr Res       Date:  2017-11-12       Impact factor: 4.791

7.  Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.

Authors:  Barnaby Nelson; Hok Pan Yuen; Stephen J Wood; Ashleigh Lin; Daniela Spiliotacopoulos; Annie Bruxner; Christina Broussard; Magenta Simmons; Debra L Foley; Warrick J Brewer; Shona M Francey; G Paul Amminger; Andrew Thompson; Patrick D McGorry; Alison R Yung
Journal:  JAMA Psychiatry       Date:  2013-08       Impact factor: 21.596

8.  Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia.

Authors:  Barbara A Cornblatt; Andrea M Auther; Tara Niendam; Christopher W Smith; Jamie Zinberg; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2007-04-17       Impact factor: 9.306

9.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.

Authors:  Tyrone D Cannon; Kristin Cadenhead; Barbara Cornblatt; Scott W Woods; Jean Addington; Elaine Walker; Larry J Seidman; Diana Perkins; Ming Tsuang; Thomas McGlashan; Robert Heinssen
Journal:  Arch Gen Psychiatry       Date:  2008-01

10.  Neurocognitive and clinical predictors of long-term outcome in adolescents at ultra-high risk for psychosis: a 6-year follow-up.

Authors:  Tim Ziermans; Sanne de Wit; Patricia Schothorst; Mirjam Sprong; Herman van Engeland; René Kahn; Sarah Durston
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

View more
  4 in total

1.  Time to Clinical Response in the Treatment of Early Onset Schizophrenia Spectrum Disorders Study.

Authors:  Jerome H Taylor; Scott Appel; Matthew Eli; Aaron Alexander-Bloch; Lawrence Maayan; Raquel E Gur; Michael H Bloch
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-07-01       Impact factor: 2.576

2.  Momentary Manifestations of Negative Symptoms as Predictors of Clinical Outcomes in People at High Risk for Psychosis: Experience Sampling Study.

Authors:  Isabell Paetzold; Karlijn S F M Hermans; Anita Schick; Barnaby Nelson; Eva Velthorst; Frederike Schirmbeck; Jim van Os; Craig Morgan; Mark van der Gaag; Lieuwe de Haan; Lucia Valmaggia; Philip McGuire; Matthew Kempton; Inez Myin-Germeys; Ulrich Reininghaus
Journal:  JMIR Ment Health       Date:  2021-11-19

3.  Exploring the effectiveness of family-based interventions for psychosis in low- and middle-income countries: a systematic review.

Authors:  Hannah Morillo; Sophie Lowry; Claire Henderson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-06-14       Impact factor: 4.519

Review 4.  Association between formal thought disorders, neurocognition and functioning in the early stages of psychosis: a systematic review of the last half-century studies.

Authors:  Oemer Faruk Oeztuerk; Alessandro Pigoni; Linda A Antonucci; Nikolaos Koutsouleris
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-07-14       Impact factor: 5.270

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.